Screening for depression among the general adult population and in women during pregnancy or the first-year postpartum: two systematic reviews to inform a guideline of the Canadian Task Force on Preventive Health Care

Table 1 Key questions to inform recommendations by the Task Force on depression screening in adults and pregnant and postpartum women

General adult population	Pregnant and postpartum population
KQ1: What are the benefits and harms of screening versus no screening for depression in the general adult population in primary care or other non-mental health clinic settings?	KQ1: What are the benefits and harms of screening versus no screening for depression during pregnancy and up to 1 year postpartum in primary care or other non-mental health clinic settings?
KQ1a: What are the benefits and harms of screening versus no screening for depression in the general adult population in primary care or other non-mental health clinic settings for patients targeted because they have characteristics that may suggest elevated risk of depression^a?	KQ1a: What are the benefits and harms of screening versus no screening for depression during pregnancy and up to 1 year postpartum in primary care or other non-mental health clinic settings for patients targeted because they have characteristics that may suggest elevated risk of depression^a?

^aCharacteristics as defined in primary studies (e.g., trauma early in life, a family history of depression), other than those specified in the exclusion criteria

ISSN: 2046-4053